BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 33220137)

  • 1. Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub-Saharan Africa: Systematic review and meta-analysis.
    Surial B; Wyser D; Béguelin C; Ramírez-Mena A; Rauch A; Wandeler G
    Liver Int; 2021 Apr; 41(4):710-719. PubMed ID: 33220137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sero-prevalence of human immunodeficiency virus-hepatitis B virus (HIV-HBV) co-infection among pregnant women attending antenatal care (ANC) in sub-Saharan Africa (SSA) and the associated risk factors: a systematic review and meta-analysis.
    Kafeero HM; Ndagire D; Ocama P; Walusansa A; Sendagire H
    Virol J; 2020 Nov; 17(1):170. PubMed ID: 33160386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Predictors of Liver Fibrosis in People Living with Hepatitis B in Senegal.
    Ramírez Mena A; Ngom NF; Tine J; Ndiaye K; Fortes L; Ndiaye O; Fall M; Gaye A; Ka D; Seydi M; Wandeler G; On Behalf Of The Sen-B Study Group
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of sero-markers and non-invasive assessment of liver cirrhosis in patients with Hepatitis B virus infection in Freetown, Sierra Leone: a cross-sectional study.
    Lakoh S; Firima E; Jiba DF; Kamara MN; Gashau W; Deen GF; Adekanmbi O; Yendewa GA
    BMC Gastroenterol; 2021 Aug; 21(1):320. PubMed ID: 34372775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.
    Wandeler G; Mulenga L; Vinikoor MJ; Kovari H; Battegay M; Calmy A; Cavassini M; Bernasconi E; Schmid P; Bolton-Moore C; Sinkala E; Chi BH; Egger M; Rauch A;
    Int J Infect Dis; 2016 Oct; 51():97-102. PubMed ID: 27596685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection, viral hepatitis and liver fibrosis among prison inmates in West Africa.
    Jaquet A; Wandeler G; Tine J; Dagnra CA; Attia A; Patassi A; Ndiaye A; de Ledinghen V; Ekouevi DK; Seydi M; Dabis F
    BMC Infect Dis; 2016 Jun; 16():249. PubMed ID: 27267370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis.
    Barth RE; Huijgen Q; Taljaard J; Hoepelman AI
    Int J Infect Dis; 2010 Dec; 14(12):e1024-31. PubMed ID: 20870439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in relation to hepatitis B virus (HBV) infection status among HIV-HBV co-infected patients in sub-Saharan Africa after immediate initiation of antiretroviral therapy.
    Mohareb AM; Kouamé GM; Gabassi A; Gabillard D; Moh R; Badje A; Emième A; Maylin S; Ménan H; Hyle EP; Delaugerre C; Danel C; Anglaret X; Lacombe K; Eholié SP; Boyd A
    J Viral Hepat; 2021 Apr; 28(4):621-629. PubMed ID: 33382189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HIV and hepatitis B virus co-infection in sub-Saharan Africa and the potential impact and program feasibility of hepatitis B surface antigen screening in resource-limited settings.
    Stabinski L; OʼConnor S; Barnhart M; Kahn RJ; Hamm TE
    J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S274-85. PubMed ID: 25768867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B screening practices and viral control among persons living with HIV in urban Senegal.
    Ramírez Mena A; Tine JM; Fortes L; Ndiaye O; Ka D; Ngom NF; Ramette A; Bittel P; Seydi M; Wandeler G;
    J Viral Hepat; 2022 Jan; 29(1):60-68. PubMed ID: 34610183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.
    Jaquet A; Wandeler G; Nouaman M; Ekouevi DK; Tine J; Patassi A; Coffie PA; Tanon A; Seydi M; Attia A; Dabis F
    J Int AIDS Soc; 2017 Feb; 19(1):21424. PubMed ID: 28362065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current situation and challenges of screening for and treating hepatitis B in sub-Saharan Africa.
    Béguelin C; Fall F; Seydi M; Wandeler G
    Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):537-546. PubMed ID: 29737218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults.
    Hawkins C; Christian B; Fabian E; Macha I; Gawile C; Mpangala S; Ulenga N; Thio CL; Ammerman LR; Mugusi F; Fawzi W; Green R; Murphy R
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):298-302. PubMed ID: 29016448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan Africa.
    Boyd A; Houghtaling L; Moh R; Chekaraou MA; Gabillard D; Eholié SP; Anglaret X; Zoulim F; Danel C; Lacombe K; For The Anrs Trivacan And Anrs VarBVA Studies
    Am J Trop Med Hyg; 2017 Dec; 97(6):1936-1942. PubMed ID: 29141712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa.
    Coffie PA; Egger M; Vinikoor MJ; Zannou M; Diero L; Patassi A; Kuniholm MH; Seydi M; Bado G; Ocama P; Andersson MI; Messou E; Minga A; Easterbrook P; Anastos K; Dabis F; Wandeler G;
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):706. PubMed ID: 29143625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of hepatitis B virus and/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: A systematic review and meta-analysis.
    Kenfack-Momo R; Kenmoe S; Takuissu GR; Ebogo-Belobo JT; Kengne-Ndé C; Mbaga DS; Tchatchouang S; Oyono MG; Kenfack-Zanguim J; Lontuo Fogang R; Mbongue Mikangue CA; Zeuko'o Menkem E; Ndzie Ondigui JL; Kame-Ngasse GI; Magoudjou-Pekam JN; Taya-Fokou JB; Bowo-Ngandji A; Nkie Esemu S; Kamdem Thiomo D; Moundipa Fewou P; Ndip L; Njouom R
    PLoS One; 2022; 17(5):e0269250. PubMed ID: 35639675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia.
    Vinikoor MJ; Mulenga L; Siyunda A; Musukuma K; Chilengi R; Moore CB; Chi BH; Davies MA; Egger M; Wandeler G;
    Trop Med Int Health; 2016 Nov; 21(11):1435-1441. PubMed ID: 27499385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B and HIV co-infection in pregnant women: indication for routine antenatal hepatitis B virus screening in a high HIV prevalence setting.
    Thumbiran NV; Moodley D; Parboosing R; Moodley P
    S Afr Med J; 2014 Apr; 104(4):307-9. PubMed ID: 25118561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort.
    Ramírez-Mena A; Glass TR; Winter A; Kimera N; Ntamatungiro A; Hatz C; Tanner M; Battegay M; Furrer H; Wandeler G; Letang E
    Open Forum Infect Dis; 2016 Sep; 3(3):ofw162. PubMed ID: 27704017
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa.
    Chotun N; Nel E; Cotton MF; Preiser W; Andersson MI
    Vaccine; 2015 Aug; 33(36):4618-22. PubMed ID: 26163924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.